menu
Blood Glucose Test Strip Market Trends, Key Players, worldwide forecast to 2027
Blood Glucose Test Strip Market Trends, Key Players, worldwide forecast to 2027
Blood Glucose Test Strip Market Information by Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical) - Forecast to 2027

Market Synopsis of Blood Glucose Test Strip Market:

Market Scenario: Blood glucose test strips are small disposable strips which are used in conjugation with blood glucose meters for monitoring and controlling diabetes. These strips have glucose oxidase impregnated on them, which when reacts with glucose present in the blood gluconic acid. The market for Blood glucose test strips is expected to grow at a CAGR of XX% by the end of the forecasted period.

 Blood Glucose Test Strip Market – Key Players

Some of the key players for Blood Glucose Test Strip Market are:

  • Abbott Laboratories
  • Acon Laboratories, Inc
  • Allmedicus
  • Apex Biotechnology Corporation
  • Ascensia Diabetes Care Holdings Ag
  • Braun Melsungen Ag
  • HMD Biomedical
  • I-Sens, Inc.
  • Lifescan, Inc.
  • Roche Diagnostics
  • Taidoc Technology Corporation

also read @ https://www.marketwatch.com/press-release/blood-glucose-test-strip-market-size-is-projected-to-grow-by-2027-research-insights-business-overview-and-share-estimation-2021-01-13

Blood Glucose Test Strip Market – Segments

The Blood Glucose Test Strip Market can be segmented in to 2 key dynamics for the convenience of the report and enhanced understanding;

By Technologies: Comprises Thick Film Electrochemical, Thin Film Electrochemical, & Optical among others

By Regions:  North America, Europe, APAC and Rest of the World.

Industry, Innovation & Related News:

July 05, 2018 – Researchers at MIT’s Little Devices Lab (US) presented a Lego-like device they have developed to perform diagnostic tests at a fraction of the cost of traditional methods.  Referred to as “plug-and-play” the engineered system device is called as Ampli blocks, can test blood glucose levels in diabetic patients and also detect viral infection.

June 22, 2018 – The U.S. Food and Drug Administration (FDA) approved a mHealth platform that includes a sensor embedded in the arm, a wearable transmitter and an app, all designed to help those with diabetes and their care teams continuously track blood-glucose levels. The Eversense CGM, system useful in continuous glucose management is developed by Senseonics and accounts for the first approved implantable device that promises up to three months of constant monitoring, contrary to other wearable CGM platforms.

April 13, 2018 - Livongo Health (US) a start-up developing connected devices and software for diabetics and other chronic conditions. The company completely devoted to providing cost-competitive aid for diabetes, has already developed its own glucometer & apps providing accurate readings. Livongo, also ships test strips to patients at no additional cost. The company announced that it has bagged the investment for USD 105 million to support the further development of its technology and a partnership from Cambia Health Solution.

April 2018 Pops! Diabetes Care, which is a Twin Cities device maker has registered its first patient in their clinical study which it is backing to see whether their device named, Pops! One, can effectively monitor blood-sugar levels for diabetics. They are also additionally partnering with the Children’s Minnesota health care system on a six-month research of 50 young patients who have been diagnosed with type 1 diabetes. They will use the Pops device to record their blood-glucose levels and alert them when they need to inject insulin. The most noticeable piece is the blood-testing device which is slightly smaller than a typical smartphone which contains a disposable cartridge with a glucose meter and three tiny lancets that have been designed so that they are less painful and easier than using a conventional finger-stick unit with individual test strips. The individual replacement cartridge can be used for up to three tests.

Blood Glucose Test Strip Market - Regional Analysis

North America market leads the Blood Glucose Test Strip Market Trends, with the significant market share. The market is further expected to reach astronomical amounts growing at a substantial CAGR throughout the forecast period (2017-2027). Well-developed healthcare sector, increasing prevalence of diabetes in the US & Canada coupled with the high per capita healthcare expenditures of these economies, together drive the regional market growth. Moreover, the presence of some of the matured market players fuels the market growth.

Europe & Asia Pacific is the second & third largest market respectively in the Global Blood Glucose Test Strip Market. Expected to be a fastest growing market Asia pacific region is estimated to grow rapidly over the projected period. Increasing healthcare expenditures along with favorable government policies of developing economies like India and China foster the market growth in APAC.

Browse Complete 110 Pages Premium Research Report Enabled with Tables and Figures @  https://www.marketresearchfuture.com/reports/blood-glucose-test-strip-market-892

Related reports

Global Cardiovascular Ultrasound Market Research Report- Forecast To 2027

Global Thymus Cancer Market Research Report- Forecast To 2027

Pleurisy Market Research Report- Global Forecast to 2027

About Market Research Future:

 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR) ), and Market Research & Consulting Services.